These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 17487253)

  • 1. Systemic inflammation and mortality in chronic obstructive pulmonary disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2007 Jan; 85(1):141-7. PubMed ID: 17487253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2005 Jan; 83(1):8-13. PubMed ID: 15759045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD and co-morbidities, with special emphasis on cardiovascular conditions.
    Löfdahl CG
    Clin Respir J; 2008 Oct; 2 Suppl 1():59-63. PubMed ID: 20298351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic obstructive pulmonary disease and cardiovascular disease: role of the systemic inflammation].
    Rossi FF; Pedone C; Antonelli Incalzi R
    Recenti Prog Med; 2011 Mar; 102(3):109-13. PubMed ID: 21572482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and biochemical markers of obstructive lung disease in the general population.
    Dahl M
    Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD.
    Tkacova R; Kluchova Z; Joppa P; Petrasova D; Molcanyiova A
    Respir Med; 2007 Aug; 101(8):1670-6. PubMed ID: 17449234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and inflammation - A further systemic complication of COPD.
    Bolton CE; Evans M; Ionescu AA; Edwards SM; Morris RH; Dunseath G; Luzio SD; Owens DR; Shale DJ
    COPD; 2007 Jun; 4(2):121-6. PubMed ID: 17530505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic obstructive pulmonary disease and cardiovascular disease].
    Alonso JL
    Arch Bronconeumol; 2010; 46 Suppl 3():18-22. PubMed ID: 20620688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammation and metabolic syndrome in stable COPD patients.
    Akpınar EE; Akpınar S; Ertek S; Sayın E; Gülhan M
    Tuberk Toraks; 2012; 60(3):230-7. PubMed ID: 23030748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease (COPD).
    Corsonello A; Pedone C; Battaglia S; Paglino G; Bellia V; Incalzi RA
    Arch Gerontol Geriatr; 2011; 53(2):190-5. PubMed ID: 21074870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease.
    Biljak VR; Pancirov D; Cepelak I; Popović-Grle S; Stjepanović G; Grubišić TŽ
    Platelets; 2011; 22(6):466-70. PubMed ID: 21506665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local inflammation occurs before systemic inflammation in patients with COPD.
    He Z; Chen Y; Chen P; Wu G; Cai S
    Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease.
    Sin DD; Man SF
    Curr Opin Pulm Med; 2008 Mar; 14(2):115-21. PubMed ID: 18303420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.